google1cd7abaa8d26ae66.html

PRACTITIONER ONLY

GENOSTICS CANCER CONFERENCE 2020

Know Your Options IV

Evidence-based adjunctive therapies for cancer patients

Featured
Convenor of the Genostics Cancer Conference 2020

Prof David Bell

Read more →
TESTING CTCS FOR PROGNOSTIC AND THERAPY RELEVANT MARKERS

Dr Joachim Fluhrer

Read more →
META ANALYSIS OF 15 YEAR DATA: CTCS AS HIGHLY SIGNIFICANT PROGNOSTIC INDICATOR

Prof Katharina Pachmann

Read more →
CANCER AND VITAMIN C. CURRENT TRIALS AND MECHANISMS OF ACTION

Dr Ian Dettman

Read more →
Immunoscore for Colon Cancer

Dr Marjane Le Bagousse

Read more →
CANCER, NK ACTIVITY AND LIFESTYLE: HOW DO THEY RELATE?

Prof Ross Grant

Read more →
Cannabis Results of Clinical Trial

Prof. Luis Vitetta

Read more →
A HOLISTIC MOLECULAR PERSPECTIVE OF CANCER DEVELOPMENT

Annemaree Miller

Read more →
IMMUNE SYSTEM. REVISION AND CHANGES WITH CHRONIC DISEASE

Dr Mark Donohoe

Read more →
PHYTOCHEMICAL INTERVENTIONS IN THE CANCER PATIENT - AN UNRESOLVED DILEMMA

Dr Christine Houghton

Read more →
SAFETY AND TOLERABILITY OF PROBIOTICS DURING CHEMOTHERAPY

Michael Thomsen (PhD candidate)

Read more →
HERBAL EXTRACTS AND SYNTHETIC FORMULATIONS FOR I.V. CANCER THERAPIES: IV CURCUMIN IN BREAST CANCER. RESULTS OF A PROSPECTIVE CLINICAL TRIAL

Dr Jürgen Arnhold

Read more →
HYPERTHERMIA IN ADDITION TO RADIOTHERAPY

A/Prof Michael Jackson

Read more →
Dr Barbara Fougere

Dr Barbara Fougere

Read more →
IMMUNOTHERAPY WITH DC VACCINES

Dr Thomas Nesselhut

Read more →
INDIVIDUALISED CANCER THERAPY: COMBINATION OF GENE-THERAPY, VACCINES, CYTOTOXIC AND BOTANICAL THERAPY

Dr Asir Kopic

Read more →
CTCS AND NK CELLS

A/Prof Eugen Molodysky

Read more →
INTERVENTIONAL ONCOLOGY TRENDS AND UPDATE. TARGETED CANCER THERAPY. TACE, TUMOUR PERFUSION AND EMBOLISATION

Prof Thomas Vogl

Read more →
C2 Smoothie

Genostics

Read more →